152 related articles for article (PubMed ID: 21605644)
1. Stabilization of tetanus toxoid formulation containing aluminium hydroxide adjuvant against freeze-thawing.
Solanki VA; Jain NK; Roy I
Int J Pharm; 2011 Jul; 414(1-2):140-7. PubMed ID: 21605644
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of tetanus toxoid formulation containing aluminium hydroxide adjuvant against agitation.
Solanki VA; Jain NK; Roy I
Int J Pharm; 2012 Feb; 423(2):297-302. PubMed ID: 22155287
[TBL] [Abstract][Full Text] [Related]
3. A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.
Li X; Thakkar SG; Ruwona TB; Williams RO; Cui Z
J Control Release; 2015 Apr; 204():38-50. PubMed ID: 25735896
[TBL] [Abstract][Full Text] [Related]
4. Freeze-thaw stress of Alhydrogel ® alone is sufficient to reduce the immunogenicity of a recombinant hepatitis B vaccine containing native antigen.
Clapp T; Munks MW; Trivedi R; Kompella UB; Braun LJ
Vaccine; 2014 Jun; 32(30):3765-71. PubMed ID: 24856785
[TBL] [Abstract][Full Text] [Related]
5. Structural perturbation of diphtheria toxoid upon adsorption to aluminium hydroxide adjuvant.
Régnier M; Metz B; Tilstra W; Hendriksen C; Jiskoot W; Norde W; Kersten G
Vaccine; 2012 Nov; 30(48):6783-8. PubMed ID: 23000120
[TBL] [Abstract][Full Text] [Related]
6. Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex.
Beck Z; Torres OB; Matyas GR; Lanar DE; Alving CR
J Control Release; 2018 Apr; 275():12-19. PubMed ID: 29432824
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of aggregation of aluminum hydroxide adjuvant during freezing and drying.
Clausi AL; Merkley SA; Carpenter JF; Randolph TW
J Pharm Sci; 2008 Jun; 97(6):2049-61. PubMed ID: 17879291
[TBL] [Abstract][Full Text] [Related]
8. Stabilisation of vaccines using trehalose (Q-T4) technology.
Gribbon EM; Sen SD; Roser BJ; Kampinga J
Dev Biol Stand; 1996; 87():193-9. PubMed ID: 8854017
[TBL] [Abstract][Full Text] [Related]
9. Comparison of oil adjuvant and aluminium phosphate-adsorbed toxoid for the passive immunization of lambs against tetanus.
Cameron CM; Van Biljon BJ; Botha WJ; Knoetze PC
Onderstepoort J Vet Res; 1983 Sep; 50(3):229-31. PubMed ID: 6646665
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application.
Maa YF; Zhao L; Payne LG; Chen D
J Pharm Sci; 2003 Feb; 92(2):319-32. PubMed ID: 12532382
[TBL] [Abstract][Full Text] [Related]
11. Active self-healing encapsulation of vaccine antigens in PLGA microspheres.
Desai KG; Schwendeman SP
J Control Release; 2013 Jan; 165(1):62-74. PubMed ID: 23103983
[TBL] [Abstract][Full Text] [Related]
12. Optimization of the formulation for a candidate lyophilised tetanus toxoid reference preparation.
Matejtschuk P; Malik K; Tierney R; Sloth Wilhelmsen E; Preneta-Blanc R; Rigsby P; Sesardic D
Biologicals; 2009 Jan; 37(1):1-7. PubMed ID: 18805022
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Propylene Glycol-Mitigated Freeze/Thaw Agglomeration of a Frozen Liquid nOMV Vaccine Formulation by Static Light Scattering and Micro-Flow Imaging.
Mensch CD; Davis HB; Blue JT
PDA J Pharm Sci Technol; 2015; 69(4):477-98. PubMed ID: 26242785
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation.
Mannhalter JW; Neychev HO; Zlabinger GJ; Ahmad R; Eibl MM
Clin Exp Immunol; 1985 Jul; 61(1):143-51. PubMed ID: 3876178
[TBL] [Abstract][Full Text] [Related]
15. Immunoenhancement with combined rabies and aluminium-adjuvanted tetanus vaccines.
Phanuphak P; Khaoplod P; Sriwanthana B; Phanpanich T; Wongurai S; Roumiantzeff M
Vaccine; 1989 Jun; 7(3):249-52. PubMed ID: 2781858
[TBL] [Abstract][Full Text] [Related]
16. Effect of microenvironment pH of aluminum hydroxide adjuvant on the chemical stability of adsorbed antigen.
Wittayanukulluk A; Jiang D; Regnier FE; Hem SL
Vaccine; 2004 Mar; 22(9-10):1172-6. PubMed ID: 15003645
[TBL] [Abstract][Full Text] [Related]
17. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.
Morefield GL; Sokolovska A; Jiang D; HogenEsch H; Robinson JP; Hem SL
Vaccine; 2005 Feb; 23(13):1588-95. PubMed ID: 15694511
[TBL] [Abstract][Full Text] [Related]
18. Stimulating role of toxoids-laden liposomes in oral immunization against diphtheria and tetanus infections.
Mirchamsy H; Manhouri H; Hamedi M; Ahourai P; Fateh G; Hamzeloo Z
Biologicals; 1996 Dec; 24(4):343-50. PubMed ID: 9088551
[TBL] [Abstract][Full Text] [Related]
19. Influences of excipients on in vitro release and in vivo performance of tetanus toxoid loaded polymer particles.
Katare YK; Panda AK
Eur J Pharm Sci; 2006 Jun; 28(3):179-88. PubMed ID: 16517132
[TBL] [Abstract][Full Text] [Related]
20. Nucleic acid aptamers stabilize proteins against different types of stress conditions.
Jetani HC; Bhadra AK; Jain NK; Roy I
J Pharm Sci; 2014 Jan; 103(1):100-6. PubMed ID: 24258428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
